Wright Investors Service’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-40,849
Closed -$1.88M 244
2016
Q3
$1.88M Sell
40,849
-119
-0.3% -$6.21K 0.78% 41
2016
Q2
$2.06M Sell
40,968
-6,669
-14% -$355K 0.85% 35
2016
Q1
$2.55M Buy
47,637
+16,298
+52% +$956K 1.01% 25
2015
Q4
$2.06M Buy
31,339
+22,570
+257% +$1.39M 0.76% 32
2015
Q3
$495K Buy
8,769
+3,973
+83% +$258K 0.22% 133
2015
Q2
$283K Buy
+4,796
New +$296K 0.14% 180

Other funds holding TEVA

Wright Investors Service's TEVA Position: Q4 2016 in Review

Wright Investors Service sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q4 2016, closing a stake of 40,849 shares — an estimated $1.88M sold.

Wright Investors Service first reported a position in TEVA in Q2 2015 and held it in 6 quarters. The position peaked at $2.55M in Q1 2016. 739 funds tracked by Wall St. Rank hold TEVA as of Q4 2016.

  • Wright Investors Service reported no remaining Teva Pharmaceutical Industries Limited position as of Q4 2016 after selling out during the quarter.
  • Wright Investors Service sold 40,849 Teva Pharmaceutical Industries Limited shares in Q4 2016, an estimated $1.88M.
  • Wright Investors Service first reported a position in Teva Pharmaceutical Industries Limited in Q2 2015 and held it in 6 quarters.
  • Wright Investors Service's Teva Pharmaceutical Industries Limited position peaked at $2.55M in Q1 2016.
  • 739 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q4 2016.

Based on Wright Investors Service's 13F filing for Q4 2016, filed 27 Jan 2017.